<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03309332</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10187</org_study_id>
    <nct_id>NCT03309332</nct_id>
  </id_info>
  <brief_title>AMPLATZER PFO Occluder Post Approval Study</brief_title>
  <acronym>PFO PAS</acronym>
  <official_title>OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this single arm, multi-center study is to confirm the safety and effectiveness
      of the AMPLATZER™ PFO Occluder in the post Approval Setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A maximum of 1214 adult subjects will be enrolled at up to 100 centers in the U.S. and
      Canada. Subjects will have follow-up at 1 month, 6 months, 12 months and annually thereafter
      through 5 years post implant.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 4, 2018</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Effectiveness: 5 year rate of recurrent ischemic stroke</measure>
    <time_frame>Through 5 years</time_frame>
    <description>5 year rate of recurrent ischemic stroke</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Safety: Device or procedure related serious adverse events</measure>
    <time_frame>Through 30 days post implant</time_frame>
    <description>Device or procedure related serious adverse events through 30 days</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1214</enrollment>
  <condition>Stroke</condition>
  <condition>Patent Foramen Ovale</condition>
  <arm_group>
    <arm_group_label>Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects implanted with the AMPLATZER™ PFO Occluder.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AMPLATZER™ PFO Occluder</intervention_name>
    <description>Implantation of the AMPLATZER™ PFO Occluder in the PFO</description>
    <arm_group_label>Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Subjects with a PFO who have had an ischemic stroke within the last 270 days

        Exclusion Criteria:

          -  Atherosclerosis or other arteriopathy of the intracranial and extracranial vessels
             associated with a &gt; 50% lumen diameter supplying the involved lesion

          -  Intra-cardiac thrombus or tumor

          -  Documented evidence of venous thrombus in the vessels through which access to the PFO
             is gained

          -  Acute or recent (within 6 months prior to consent) myocardial infarction or unstable
             angina

          -  Left ventricular aneurysm or akinesis

          -  Mitral valve stenosis or severe mitral regurgitation requiring intervention
             irrespective of etiology

          -  Aortic valve stenosis (mean gradient &gt;40 mmHg) or severe aortic valve regurgitation

          -  Mitral or aortic valve vegetation or prosthesis

          -  Aortic arch plaques protruding greater than 4mm into the aortic lumen

          -  Left ventricular dilated cardiomyopathy with depressed left ventricular ejection
             fraction (LVEF less than 35%)

          -  Subjects with other source of right to left shunts, including an atrial septal defect
             and/or fenestrated septum

          -  Chronic, persistent, or paroxysmal atrial fibrillation or atrial flutter

          -  Pregnancy at the time of implant

          -  Age less than 18 years or greater than 60 years at time of consent

          -  Active endocarditis or other untreated infections

          -  Organ failure (kidney, liver or lung) Kidney failure: Poor urine output of less than 1
             cc/kg/hr with elevated BUN levels (above the normal reference range for the laboratory
             at the investigational site).

        Liver failure: Liver enzymes outside the normal reference range for the laboratory at the
        investigational site: poor liver function as assessed by elevated PT (above the normal
        reference range for the laboratory at the investigational site) and low total protein and
        albumin (below the normal reference range for the laboratory at the investigational site).

        Lung failure: Respiratory failure is retention of carbon dioxide more than 60 mmHg, poor
        oxygenation with oxygen tension less than 40 mmHg in room air or the need for assisted
        ventilation.

          -  Uncontrolled hypertension defined as sustained elevated systemic blood pressure to
             more than 160/90 mmHg with medications

          -  Uncontrolled diabetes defined as continued elevated glucose levels in spite of
             administration of insulin/levels of more than 200 mg with presence of glucose in the
             urine

          -  Diagnosis of lacunar infarct probably due to intrinsic small vessel as qualifying
             stroke event Definition: Ischemic stroke in the distribution of a single, small deep
             penetrating vessel in a patient with any of the following: 1) a history of
             hypertension (except in the first week post stroke); 2) history of diabetes mellitus;
             3) Age &gt;/= 50; or 4) MRI or CT shows leukoaraiosis greater than symmetric,
             well-defined periventricular caps or bands (European Task Force on Age-Related White
             Matter Changes rating scale score &gt; 0)

          -  Arterial dissection as cause of stroke

          -  Subjects who test positive with one of the following hypercoagulable states;
             Anticardiolipin Ab of the IgG or IgM, Lupus anticoagulant, B2-glycoprotein-1
             antibodies or persistently elevated fasting plasma homocysteine despite medical
             therapy

          -  Unable to take antiplatelet therapy

          -  Anatomy in which the AMPLATZERTM PFO Occluder device size required would interfere
             with intracardiac or intravascular structures such as valves or pulmonary veins

          -  Vasculature, through which access to the PFO is gained, is inadequate to accommodate
             the appropriate sheath size

          -  Malignancy or other illness where life expectancy is less than 2 years

          -  Subjects who will not be available for follow-up for the duration of the trial

          -  Inability to obtain Informed Consent from patient

          -  Index stroke of poor outcome (modified Rankin score greater than 3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barathi Sethuraman, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Abbott</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maren Wagner</last_name>
    <phone>651 756 5585</phone>
    <email>mwagner2@sjm.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Gilfilan</last_name>
      <phone>323-783-7387</phone>
      <email>Kimberly.R.Gilfilan@kp.org</email>
    </contact>
    <investigator>
      <last_name>Somjot Brar, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Perlas</last_name>
      <phone>650-723-2094</phone>
      <email>mperlas@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>David Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Los Robles Hospital and Medical Center</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Weeks, RN, BA</last_name>
      <phone>805-370-4184</phone>
      <email>Nancy.Weeks@HCAhealthcare.com</email>
    </contact>
    <investigator>
      <last_name>Vishva Dev, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Potts</last_name>
      <phone>904-450-8645</phone>
      <email>patricia.potts@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Samer Garas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baptist Medical Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doran Cassidy, CRC</last_name>
      <phone>904-202-7218</phone>
      <email>doran.cassidy@bmc.jax.com</email>
    </contact>
    <investigator>
      <last_name>Ruby Satpathy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orlando Health</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Noel</last_name>
      <phone>321-841-3686</phone>
      <email>Henry.Noel@orlandohealth.com</email>
    </contact>
    <investigator>
      <last_name>VijayKumar Kasi, PhD, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>WellStar Kennestone Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>98502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pamela Hyde</last_name>
      <phone>770-793-5147</phone>
      <email>Pamela.Hyde@wellstar.org</email>
    </contact>
    <investigator>
      <last_name>Amar Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Prairie Education and Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>63146</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Shugart</last_name>
      <phone>217-492-9100</phone>
      <email>cshugart@prairieresearch.com</email>
    </contact>
    <investigator>
      <last_name>Nilesh Goswami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Bogard</last_name>
      <phone>317-338-6450</phone>
      <email>Laurie.Bogard@theheartcenter.com</email>
    </contact>
    <investigator>
      <last_name>James Hermiller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah Gans</last_name>
      <email>sgans@tuftsmedicalcenter.org</email>
    </contact>
    <investigator>
      <last_name>David Thaler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48084</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashish Solanki</last_name>
      <phone>313-916-3571</phone>
      <email>asolank2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>William O'Neill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Duluth</city>
        <state>Minnesota</state>
        <zip>55805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tricia Keinanen</last_name>
      <phone>218-786-4868</phone>
      <email>Trica.Keinanen@essentiahealth.org</email>
    </contact>
    <investigator>
      <last_name>Wilson Ginete, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Cloud Hospital</name>
      <address>
        <city>Saint Cloud</city>
        <state>Minnesota</state>
        <zip>56303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Douvier</last_name>
      <phone>320-251-2700</phone>
      <email>douvierA@centracare.com</email>
    </contact>
    <investigator>
      <last_name>Jacob Dutcher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Anthony's Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Mechem</last_name>
      <phone>314-525-1697</phone>
      <email>carol.mechem@samcstl.org</email>
    </contact>
    <investigator>
      <last_name>Christopher Allen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital/ Cornell University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Marine</last_name>
      <phone>212-746-2516</phone>
      <email>mem9065@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Geoffrey Bergman, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant Health Heart and Vascular Research</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Burdon</last_name>
      <phone>704-264-1400</phone>
      <email>rburdon@novanthealth.org</email>
    </contact>
    <investigator>
      <last_name>Olseun Alli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moses H Cone Memorial Hospital</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27358</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jebta Chalmers</last_name>
      <phone>336-832-3798</phone>
      <email>kenya.chalmers@conehealth.com</email>
    </contact>
    <investigator>
      <last_name>Michael Cooper, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Forsyth Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27358</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelli Melton</last_name>
      <phone>336-718-5807</phone>
      <email>kellimelton@novanthealth.org</email>
    </contact>
    <investigator>
      <last_name>Samuel Turner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jewish Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cendi Kegley</last_name>
      <phone>513-952-5104</phone>
      <email>crkegley@mercy.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Rapp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luba Mazanec</last_name>
      <phone>614-247-7733</phone>
      <email>luba.mazanec@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Konstantinos Boudoulas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Providence Heart and Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Derridinger</last_name>
      <phone>503-216-7275</phone>
      <email>Olivia.Derridinger@providence.org</email>
    </contact>
    <investigator>
      <last_name>Ethan Korngold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacia Lutz</last_name>
      <phone>717-531-1452</phone>
      <email>slutz1@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Kozak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Tennessee Heart Consultants</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Polk</last_name>
      <phone>865-218-7535</phone>
      <email>beth.polk@tennova.com</email>
    </contact>
    <investigator>
      <last_name>Malcolm Foster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Turrentine, MPH, CCRP</last_name>
      <phone>713-500-5683</phone>
      <email>Elizabeth.P.Turrentine@UTH.TMC.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Smalling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Richards</last_name>
      <phone>757-388-1568</phone>
      <email>cjricha1@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Paul Mahoney, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2017</study_first_submitted>
  <study_first_submitted_qc>October 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 13, 2017</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Foramen Ovale, Patent</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

